Merck (MRK) Announces Presentation of Phase 2 Results for MK-7264
Tweet Send to a Friend
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of results from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE